Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc. presents a compelling investment opportunity with a current enterprise value of approximately $430 million, which suggests significant upside potential, possibly 8-10 times the current share price, particularly if its partnership with Novoproves proves successful. The company's clinical pipeline, including promising candidates like SEP-631, has the potential to achieve blockbuster status similar to established therapies, thereby enhancing long-term revenue prospects. Furthermore, Septerna's strategic collaboration with Novo Nordisk allows for access to the expansive obesity market in a low-risk and capital-efficient manner, strengthening its long-term value creation opportunities.

Bears say

The financial outlook for Septerna Inc appears negative due to several inherent risks, primarily related to potential delays and setbacks in the clinical development of its candidates, particularly SEP-631. The company faces significant partnership risks, particularly in its relationship with Novo Nordisk, which could further impact its ability to secure approvals for key drug candidates. Additionally, lower-than-expected market penetration rates and the possibility of long-term dilution pose further challenges to the company’s financial stability and valuation.

Septerna Inc (SEPN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.